Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FRVS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,428
Award facts
- Contract value 100% obligated
- $40,427.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,427.97 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical and medical supply offerings. The SPE2DX prime contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other government healthcare systems worldwide. This specific delivery order for Gemtesa—an overactive bladder treatment—exemplifies the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FRVS6?
SPE2DB25FRVS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FRVS6 worth?
The government has obligated $40,428 on SPE2DB25FRVS6.
Is contract SPE2DB25FRVS6 an order under another contract?
Yes. SPE2DB25FRVS6 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRVS6 competed?
The extent of competition for SPE2DB25FRVS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award